The impact of pre-IPO performance pressure on research and development investments of an IPO firm: Evidence from China

We derive a simple model to show that pre-IPO performance pressure has a negative impact on an IPO applicant's research and development investments. The findings from the Chinese IPOs in the growth enterprise market (GEM) are consistent with the  model's predictions . Further analysis suggests that when the time to listing is shorter, the adverse impact of performance pressure on R&D investments is stronger. While the objective of the GEM is to encourage innovative firms to raise new capital via IPOs to enhance their innovations in the future, the cutting of R&D investments to enhance the probability of receiving IPO approval defeats the purpose. Our findings suggest that it may be useful for a regulatory authority to consider multi-dimensional criteria in IPO approvals for GEMs instead of heavily relying on the pre-IPO performance to sustain a healthy IPO market and innovation activities of a country.